Clinical Trial Update: Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions [Phase 2]

View source ↗

Summary

Phase 2 trial update on vandetanib for preventing progression from precancerous head and neck lesions; results posted after completion. The study involves lip a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lip and Oral Cavity Squamous Cell Carcinoma
• Oral Cavity Verrucous Carcinoma
• Precancerous Condition

Drugs mentioned

• Vandetanib (vandetanib)

Snippet

Sponsor: University of Chicago | Conditions: Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-14